Yue Wei, PhD, discusses using single-cell sequencing and patient data to validate HMA effects on megakaryocyte maturation in MDS.
Yue Wei, PhD
Advertisement
Yue Wei, PhD, is an assistant professor in the Department of Leukemia, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center in Houston.
Articles by Yue Wei, PhD
Yue Wei, PhD, discusses how HMAs promote late-stage megakaryocyte maturation and platelet production in MDS mouse models.
Yue Wei, PhD, discusses the correlation between TET2 mutations and platelet recovery in patients with MDS receiving hypomethylating agents.
Yue Wei, PhD, discusses how TET2 mutations influence platelet response and prognosis in patients with MDS receiving hypomethylating agents.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5